1. Home
  2. GDTC vs JZ Comparison

GDTC vs JZ Comparison

Compare GDTC & JZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CytoMed Therapeutics Limited

GDTC

CytoMed Therapeutics Limited

HOLD

Current Price

$1.00

Market Cap

12.4M

Sector

Health Care

ML Signal

HOLD

Logo Jianzhi Education Technology Group Company Limited

JZ

Jianzhi Education Technology Group Company Limited

HOLD

Current Price

$0.82

Market Cap

12.6M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
GDTC
JZ
Founded
2018
2011
Country
Singapore
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Consumer Services
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
12.4M
12.6M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
GDTC
JZ
Price
$1.00
$0.82
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
7.3K
355.5K
Earning Date
04-24-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$5.37
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.73
$0.25
52 Week High
$3.68
$2.93

Technical Indicators

Market Signals
Indicator
GDTC
JZ
Relative Strength Index (RSI) 45.73 45.85
Support Level $0.97 $0.80
Resistance Level $1.11 $1.48
Average True Range (ATR) 0.05 0.17
MACD -0.00 -0.02
Stochastic Oscillator 32.48 5.51

Price Performance

Historical Comparison
GDTC
JZ

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

About JZ Jianzhi Education Technology Group Company Limited

Jianzhi Education Technology Group Co Ltd engages in developing educational content to fulfill the massive demand for high-quality, professional development training resources in China. The company and its subsidiaries VIE and VIEs generate subscription revenue through selling subscriptions to online learning platforms, higher education institutions, and other institutional customers under a B2B2C model mainly through the platform of Sentu Academy; offering subscriptions concerning educational content in mobile video packages directly to end users under a B2C model through the platforms such as Fish Learning or Light Class, etc. It has two operating segments: Educational content services and other services and IT-related solution services.

Share on Social Networks: